Myocardial infarction (MI) causes irreversible cardiomyocyte (CM) loss, adverse ventricular remodeling, and heart failure due to the limited regenerative capacity of the adult human heart. Effective cardiac repair requires the coordinated induction of CM proliferation and angiogenesis without promoting fibrosis....
Y. Gong, M. Generali, H. Renikunta et al.· European Heart Journal· 0 citations
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a leading cause of sudden cardiac death in the young. However, the prevalence and clinical penetrance of ARVC-associated pathogenic/likely pathogenic (P/LP) variants in the general population remain poorly defined.
In 34,202 UK Biobank participants...
Z. Zhang, F. Duru, L. Chen· European Heart Journal· 0 citations
Heart failure with preserved ejection fraction (HFpEF) is a growing global burden with limited therapeutic options. While lipid metabolic disorders are hallmarks of HFpEF, the specific contribution of imbalanced -6/-3 polyunsaturated fatty acids (PUFAs) to myocardial lipid handling remains poorly understood. This...
Z. Zhang, J. Wang, W. Zhang et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.